Literature DB >> 7513163

Identification of an alternatively spliced form of the murine homologue of B7.

M Inobe1, P S Linsley, J A Ledbetter, Y Nagai, M Tamakoshi, T Uede.   

Abstract

B7 on antigen presenting cells is a costimulatory ligand necessary for full activation of T cell. Receptors for B7 have been known as CD28 or CTLA4. We here show that in addition to B7 mRNA, an alternatively spliced mRNA (designated as MB7-2 mRNA), that immunoglobulin (Ig)C-like domain coded by exon 3 has been spliced out, is found in activated murine splenic B cells by reverse transcriptase-polymerase chain reaction analysis. Chinese hamster ovary (CHO) cells transfected with MB7-2 bound CTLA4Ig less well than those expressing B7, but bound CD28Ig to a similar extent, indicating that IgV-like domain contains the complete binding site for CD28. In addition, IgC-like domain may participate in an increase in the affinity for CTLA4. Thus, MB7-2 represents a new form of the murine B7 with different receptor binding properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513163     DOI: 10.1006/bbrc.1994.1469

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.

Authors:  T Shimizu; C Sano; H Tomioka
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Enhancement of antigen-presenting ability of B lymphoma cells by partial inhibition of protein synthesis through inducing B7-1 expression.

Authors:  T Aoi; H Nakano; Y Tanaka; T Kakiuchi
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  Enhancement of B7-1 (CD80) expression on B-lymphoma cells by irradiation.

Authors:  A Seo; F Ishikawa; H Nakano; H Nakazaki; K Kobayashi; T Kakiuchi
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

4.  Identification and characterization of an alternative cytotoxic T lymphocyte-associated protein 4 binding molecule on B cells.

Authors:  M Murakami; Y Takahashi; Y Isashi; S Kon; W Y Jia; M Inobe; R Abe; T Uede
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Experimental study on the antitumor effect of mouse B7-1 gene.

Authors:  S Qu; R Liu; J Wang; Y Wang
Journal:  J Tongji Med Univ       Date:  1999

7.  Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells.

Authors:  Fumio Ishikawa; Hideki Nakano; Akira Seo; Yayoi Okada; Hideko Torihata; Yuriko Tanaka; Tetsuya Uchida; Hidekazu Miyake; Terutaka Kakiuchi
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

8.  Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells.

Authors:  Hideko Torihata; Fumio Ishikawa; Yayoi Okada; Yuriko Tanaka; Tetsuya Uchida; Toru Suguro; Terutaka Kakiuchi
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

9.  Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.

Authors:  Y Guo; Y Wu; M Zhao; X P Kong; Y Liu
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.

Authors:  C A Fargeas; A Truneh; M Reddy; M Hurle; R Sweet; R P Sékaly
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.